2011•Shiyong zhongliu zazhiRequires access

Effect of sodium valproate on proliferation and expression of VEGF and bFGF mRNA in human liver cancer cell line Bel-7402

HE Geng-jin

Open publisher page 0 citations

Abstract

Objective To investigate the inhibiting effect of sodium valproate in human liver cancer Bel-7402 cells and its mechanism.Methods The cell proliferation was determined by MTT assay.Cell apoptosis was analyzed by flow cytometry(FCM) .In addition,the expression level of VEGF and bFGF were analyzed by RT-PCR and Western blot.Results Sodium valproate inhibited the proliferation of Bel-7402 cells in a dose-and time-dependent manner.The apoptotic rate was significantly higher in the cells treated with 1,2 and 4 mmol/L VPA for 72 h than untreated cells [(8.79±0.53) %,(18.65±1.02) %,(36.41±1.93) % vs(2.78±0.32) %].The expression levels of VEGF and bFGF were down-regulated in a dose dependent manner in Bel-7402 treated with VPA for 72 h(P0.05) .Conclusion Sodium valproate can inhibit the proliferation of Bel-7402 cells and the possible mechanism is related to the decrease of VEGF and bFGF expression.

About this research paper

What this paper is about

Objective To investigate the inhibiting effect of sodium valproate in human liver cancer Bel-7402 cells and its mechanism.Methods The cell proliferation was determined by MTT assay.Cell apoptosis was analyzed by flow cytometry(FCM) .In addition,the expression level of VEGF and bFGF were analyzed by RT-PCR and Western blot.Results Sodium valproate inhibited the proliferation of Bel-7402 cells in a dose-and time-dependent manner.The apoptotic rate was significantly higher in the cells treated with 1,2 and 4 mmol/L VPA for 72 h than untreated cells [(8.79±0.53) %,(18.65±1.02) %,(36.41±1.93) % vs(2.78±0.32) %].The expression levels of VEGF and bFGF were down-regulated in a dose dependent manner in Bel-7402 treated with VPA for 72 h(P0.05) .Conclusion Sodium valproate can inhibit the proliferation of Bel-7402 cells and the possible mechanism is related to the decrease of VEGF and bFGF expression.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the inhibiting effect of sodium valproate in human liver cancer Bel-7402 cells and its mechanism.Methods The cell proliferation was determined by MTT assay.Cell apoptosis was analyzed by flow cytometry(FCM) .In addition,the expression level of VEGF and bFGF were analyzed by RT-PCR and Western blot.Results Sodium valproate inhibited the proliferation of Bel-7402 cells in a dose-and time-dependent manner.The apoptotic rate was significantly higher in the cells treated with 1,2 and 4 mmol/L VPA for 72 h than untreated cells [(8.79±0.53) %,(18.65±1.02) %,(36.41±1.93) % vs(2.78±0.32) %].The expression levels of VEGF and bFGF were down-regulated in a dose dependent manner in Bel-7402 treated with VPA for 72 h(P0.05) .Conclusion Sodium valproate can inhibit the proliferation of Bel-7402 cells and the possible mechanism is related to the decrease of VEGF and bFGF expression.

Key concepts: Apoptosis, Cell growth, Cell culture, Flow cytometry, Western blot, MTT assay, Messenger RNA, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of sodium valproate on proliferation and expression of VEGF and bFGF mRNA in human liver cancer cell line Bel-7402 — Research Paper | ScholarLens